GENE ONLINE|News &
Opinion
Blog

ASCO 2024
ASCO 2024 ASCO Breakthrough 2024
ASCO Breakthrough 2024: Radiation Alone Works as Well as Chemoradiation for Low-Risk Nasopharyngeal Cancer
2024-08-08
ASCO 2024 ASCO 2024US BIO
Merck Buys EyeBio for $3B and Shares Global Policy Perspectives During BIO in San Diego
2024-06-20
ASCO 2024 ASCO 2024US BIO
Johnson & Johnson’s Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech Partnerships at BIO 2024
2024-06-20
ASCO 2024 ASCO 2024ASCO Releases
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
ASCO 2024 ASCO Previews
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
ASCO 2024 ASCO 2024Oncology
Major Cancer Research Publications at the 2024 American Society of Clinical Oncology Annual Meeting
2024-05-28
LATEST
Unity Technologies Announces Unity 7 Development Roadmap at Unite Seoul
2026-07-20
Road Traffic Injuries Caused 1.34 Million Deaths and 51 Million Injuries Globally in 2023
2026-07-20
Ross Stores Expands to 2,150 Locations With 47 New Openings
2026-07-20
SRMMF Issues Formal Statement Clarifying Performance Rights Status on July 20, 2026
2026-07-20
Study Finds Collagen Peptide Supplementation May Support Bone Health in Female Runners
2026-07-20
Aspire Biopharma Signs X Games Medalist Jarryd McNeil to Promote BUZZ BOMB Line
2026-07-20
Pipistrel Introduces Voyager Aircraft With Digital Avionics for Flight Training
2026-07-20
READ MORE
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
SEE MORE
Scroll to Top